TY - JOUR
T1 - Core outcomes in neonatal encephalopathy: A qualitative study with parents
AU - Quirke, Fiona
AU - Ariff, Shabina
AU - Battin, Malcolm
AU - Bernard, Caitlin
AU - Bloomfield, Frank
AU - Daly, Mandy
AU - Devane, Declan
AU - Hass, David
AU - Healy, Patricia
AU - Hurley, Tim
AU - Kibet, Vincent
AU - Kirkham, Jamie
AU - Koskei, Sarah
AU - Meher, Shireen
AU - Molloy, Eleanor
AU - Niaz, Maira
AU - Bhraonáin, Elaine
AU - Okaronon, Christabell
AU - Tabassum, Farhana
AU - Walker, Karen
AU - Biesty, Linda
N1 - Funding Information:
On behalf of the COHESION Study team, we would sincerely like to thank all parents who gave their time and took part in our interviews. We would also like to thank the Irish Neonatal Health Alliance, Hope for HIE, Miracle Babies Foundation and Life’s Little Treasures Foundation for sharing our study information and playing a vital part in recruitment to this study. Dr Malcolm Battin would like to acknowledge the receipt of his research fellowship (Health Research Council of New Zealand grant number 20/030).
Funding Information:
This study was conducted as part of a PhD project funded by the Health Research Board (HRB) as part of the Neonatal Encephalopathy PhD Training Network (NEPTuNE).
Publisher Copyright:
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..All right reserved.
PY - 2022/7/25
Y1 - 2022/7/25
N2 - Objective To identify the outcomes considered important to parents or caregivers of infants diagnosed with neonatal encephalopathy, hypoxic ischaemic encephalopathy or birth asphyxia in high-income and low-to middle-income countries (LMiCs), as part of the outcome-identification process in developing a core outcome set (COS) for the treatment of neonatal encephalopathy. Design A qualitative study involving 25 semistructured interviews with parents or other family members (caregivers) of infants who were diagnosed with, and treated for, neonatal encephalopathy, hypoxic ischaemic encephalopathy or birth asphyxia. Setting Interviews were conducted in high-income countries (HiCs) (n=11) by Zoom video conferencing software and in LMiCs (n=14) by phone or face to face. Findings Parents identified 54 outcomes overall, which mapped to 16 outcome domains. The domains identified were neurological outcomes, respiratory outcomes, gastrointestinal outcomes, cardiovascular outcomes, motor development, cognitive development, development (psychosocial), development (special senses), cognitive development, development (speech and social), other organ outcomes, survival/living outcomes, long-term disability, hospitalisation, parent-reported outcomes and adverse events. Conclusions This study provides insight into the outcomes that parents of infants diagnosed with neonatal encephalopathy have identified as the most important, to be considered in the process of developing a COS for the treatment of neonatal encephalopathy. We also provide description of the processes employed to ensure the inclusion of participants from LMiCs as well as HiCs.
AB - Objective To identify the outcomes considered important to parents or caregivers of infants diagnosed with neonatal encephalopathy, hypoxic ischaemic encephalopathy or birth asphyxia in high-income and low-to middle-income countries (LMiCs), as part of the outcome-identification process in developing a core outcome set (COS) for the treatment of neonatal encephalopathy. Design A qualitative study involving 25 semistructured interviews with parents or other family members (caregivers) of infants who were diagnosed with, and treated for, neonatal encephalopathy, hypoxic ischaemic encephalopathy or birth asphyxia. Setting Interviews were conducted in high-income countries (HiCs) (n=11) by Zoom video conferencing software and in LMiCs (n=14) by phone or face to face. Findings Parents identified 54 outcomes overall, which mapped to 16 outcome domains. The domains identified were neurological outcomes, respiratory outcomes, gastrointestinal outcomes, cardiovascular outcomes, motor development, cognitive development, development (psychosocial), development (special senses), cognitive development, development (speech and social), other organ outcomes, survival/living outcomes, long-term disability, hospitalisation, parent-reported outcomes and adverse events. Conclusions This study provides insight into the outcomes that parents of infants diagnosed with neonatal encephalopathy have identified as the most important, to be considered in the process of developing a COS for the treatment of neonatal encephalopathy. We also provide description of the processes employed to ensure the inclusion of participants from LMiCs as well as HiCs.
KW - Neonatal encephalopathy
KW - hypoxic ischemic encephalopathy
KW - parent
KW - outcomes
KW - core outcome set
KW - qualitative interviews
KW - parent-important outcomes
KW - high-income countries
KW - low-to middle- income countries
KW - Qualitative research
KW - Neurology
KW - Neonatology
U2 - 10.1136/bmjpo-2022-001550
DO - 10.1136/bmjpo-2022-001550
M3 - Article
SN - 2399-9772
VL - 6
JO - BMJ Paediatrics open
JF - BMJ Paediatrics open
IS - 1
M1 - e001550
ER -